MEK inhibitor (study drug)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MEK inhibitor (study drug), covering 2025-08-08 to 2025-08-08. Get the full timeline:
Most recent: Clinical Trial Update: Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy [Phase 2]